Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up

BACKGROUND: Immunosuppressive therapy after life-saving kidney transplantation increases the risk of infection, cardiovascular diseases, metabolic diseases, and cancer. To date, four centers (three in the USA and one in South Korea) have reported clinical tolerance trials in kidney transplantation....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Transl Med
Autori principali: Wang, Xuanchuan, Yang, Cheng, Hu, Linkun, Wei, Zheng, Tang, Qunye, Chen, Bing, Ji, Yuan, Xu, Ming, Zeng, Zhaochong, Rong, Ruiming, Zhu, Tongyu
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7723571/
https://ncbi.nlm.nih.gov/pubmed/33313123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2502a
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi